What's in Your Water? EPA Finally Has an Answer

EPA names microplastics and pharmaceuticals as drinking water priorities for the first time, opening a formal federal regulatory path

4 Jun 2026

American tap water just got a longer list of things to worry about. On April 2, 2026, the EPA named microplastics and pharmaceuticals as priority contaminant groups under the Safe Drinking Water Act for the first time, opening a formal federal regulatory pathway for substances already detected in human blood, organs, and public water supplies nationwide.

EPA Administrator Lee Zeldin and Health Secretary Robert F. Kennedy Jr. announced the draft Sixth Contaminant Candidate List jointly. It places microplastics alongside pharmaceuticals, PFAS, disinfection byproducts, 75 chemicals, and nine microbes as substances of active federal concern. Enforceable limits do not follow automatically from the listing, but the designation triggers research obligations, prioritizes federal funding, and positions these substances for potential future drinking water standards.

Parallel pressure is building on a separate regulatory track. Seven governors petitioned the EPA in late 2025 to include microplastics in the next Unregulated Contaminant Monitoring Rule, and the agency submitted that proposed rule for White House review in March 2026. If finalized this year, it would mark the first federally mandated microplastics testing requirement ever placed on US water systems, a threshold with no prior federal precedent for utilities of any size.

Health benchmarks for 374 pharmaceuticals were also released alongside the list, giving states, tribes, and local systems a practical risk-assessment tool before enforceable standards arrive. California is already moving faster than the federal timeline. Large water systems in the state begin treated-water microplastics monitoring in fall 2026, and their results are expected to produce the first major national occurrence dataset for this contaminant class.

For utilities across the country, the regulatory horizon is shifting faster than most anticipated. Those that build detection and treatment capacity now will define what flows from American taps for years to come.